1. Home
  2. ADAM vs CBLL Comparison

ADAM vs CBLL Comparison

Compare ADAM & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ADAM

Adamas Trust Inc.

HOLD

Current Price

$8.43

Market Cap

826.7M

Sector

Technology

ML Signal

HOLD

Logo CeriBell Inc.

CBLL

CeriBell Inc.

HOLD

Current Price

$23.62

Market Cap

935.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADAM
CBLL
Founded
2003
2014
Country
United States
United States
Employees
N/A
300
Industry
Computer Software: Prepackaged Software
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
826.7M
935.3M
IPO Year
2003
2024

Fundamental Metrics

Financial Performance
Metric
ADAM
CBLL
Price
$8.43
$23.62
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$9.17
$23.20
AVG Volume (30 Days)
921.1K
269.9K
Earning Date
04-29-2026
05-11-2026
Dividend Yield
11.87%
N/A
EPS Growth
196.49
56.93
EPS
0.87
N/A
Revenue
N/A
$89,063,000.00
Revenue This Year
N/A
$29.57
Revenue Next Year
$5.08
$28.44
P/E Ratio
$10.11
N/A
Revenue Growth
N/A
36.09
52 Week Low
$6.45
$10.85
52 Week High
$10.36
$25.63

Technical Indicators

Market Signals
Indicator
ADAM
CBLL
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
ADAM
CBLL

About ADAM Adamas Trust Inc.

Adamas Trust Inc is an internally-managed REIT for U.S. federal income tax purposes, in the business of acquiring, investing in, financing, and managing mainly mortgage-related single-family and multi-family residential assets. Its objective is to deliver long-term stable distributions to its stockholders over changing economic conditions through a combination of net interest spread and capital gains from a diversified investment portfolio. The company's investment portfolio includes credit-sensitive single-family and multi-family assets.

About CBLL CeriBell Inc.

CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.

Share on Social Networks: